Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System

ABSTRACT:

SUBMITTER: Baroukhian J 

PROVIDER: S-EPMC11695399 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature